BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 12 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 12 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 12 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 13 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 13 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 14 hours ago Atmus Welcomes Heath Sharp to Board of Directors 16 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 16 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 12 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 12 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 12 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 13 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 13 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 14 hours ago Atmus Welcomes Heath Sharp to Board of Directors 16 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 16 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT

Biocept, Inc. (BIOC) Q3 2022 Earnings Call Transcript

Biocept, Inc. (NASDAQ: BIOC) Q3 2022 earnings call dated Nov. 28, 2022 Corporate Participants: Jody Cain — Investor Relations Samuel D. Riccitelli — Chairman and interim President and Chief…

Biocept Inc (BIOC) Q2 2021 Earnings Call Transcript

Biocept Inc (NASDAQ:BIOC) Q2 2021 earnings call dated Aug. 16, 2021. Corporate Participants: Bruce Voss — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim Kennedy — Chief…

Market News

Biocept Inc (BIOC) Q4 2020 Earnings Call

Biocept Inc (NASDAQ: BIOC) Q4 2020 earnings call dated Mar. 29, 2021. Corporate Participants: Jody Cain — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim…

Biocept Inc (BIOC) Q4 2020 Earnings Call Transcript

Biocept Inc (NASDAQ: BIOC) Q4 2020 earnings call dated Mar. 29, 2021. Corporate Participants: Jody Cain — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim…

Market News

Biocept Inc (BIOC) Q3 2020 Earnings Call

Biocept Inc  (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020 Corporate Participants: Bruce Voss — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim…

Biocept Inc (BIOC) Q3 2020 Earnings Call Transcript

Biocept Inc  (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020 Corporate Participants: Bruce Voss — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim…

Biocept Inc. (BIOC) Q2 2020 Earnings Call Transcript

Biocept Inc. (NASDAQ: BIOC) Q2 2020 earnings call dated Aug. 12, 2020 Corporate Participants: Jody Cain — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim…

Analysis

Biocept (BIOC) – Is it worth buying?

Investing in microcap stocks are considered to be risky; even higher so in uncertain market environments like the one we are seeing right now. So…